Abuse-Deterrent Opioids: Evaluation and Labeling Guidance for Industry

Source: U.S. Food and Drug Administration

This April 2015 FDA report is intended “to assist sponsors who wish to develop opioid drug products with potentially abuse-deterrent properties.” It notes that “Prescription opioid products are an important component of modern pain management. However, abuse and misuse of these products have created a serious and growing public health problem. One potentially important step towards the[…]

April 8, 2015 |